Utrophin is a ubiquitously expressed cytoskeletal protein which is an
important structural component of the mammalian neuromuscular junction
. It shows extensive sequence similarity to dystrophin leading to post
ulation that utrophin may be able to compensate for the absence of dys
trophin in Duchenne muscular dystrophy (DMD) patients. In order to stu
dy the transcriptional control of utrophin expression including its re
gulation at the neuromuscular junction, and as a first step in the dev
elopment of a potential DMD therapy, we have cloned the utrophin promo
ter region from human and mouse. The utrophin promoter is associated w
ith a CpG island at the 5'-end of the gene, and sequence analysis of t
he 5'-UTR reveals several Sp1 binding sites and the absence of TATA or
CAAT motifs. Transcription is initiated at one major and three minor
sites. Using deletion constructs, we have defined an active promoter r
egion of 155 bp. The first exon and 900 bp upstream display limited se
quence conservation between human and mouse. The core sequence TTCCGG
of the N box which regulates synaptic expression of other genes is als
o present and may be involved in regulating the specific expression of
utrophin at the postsynaptic membrane. This study provides the basis
for the understanding of the regulatory mechanism that controls utroph
in expression and provides the data needed to develop methods for the
upregulation of utrophin in DMD patients.